These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19082254)

  • 1. Costing of scaling up HIV/AIDS treatment in Mexico.
    Bautista-Arredondo S; Dmytraczenko T; Kombe G; Bertozzi SM
    Salud Publica Mex; 2008; 50 Suppl 4():S437-44. PubMed ID: 19082254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011.
    Nosyk B; Montaner JS; Yip B; Lima VD; Hogg RS;
    Med Care; 2014 Apr; 52(4):362-9. PubMed ID: 24848208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
    PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary costs of HIV healthcare in the HAART era.
    Gebo KA; Fleishman JA; Conviser R; Hellinger J; Hellinger FJ; Josephs JS; Keiser P; Gaist P; Moore RD;
    AIDS; 2010 Nov; 24(17):2705-15. PubMed ID: 20859193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.
    Pillai N; Foster N; Hanifa Y; Ndlovu N; Fielding K; Churchyard G; Chihota V; Grant AD; Vassall A
    PLoS One; 2019; 14(2):e0210622. PubMed ID: 30742623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.
    Nosyk B; Lima V; Colley G; Yip B; Hogg RS; Montaner JS
    Pharmacoeconomics; 2015 Mar; 33(3):243-53. PubMed ID: 25404425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa.
    Rosen S; Ketlhapile M
    Trop Med Int Health; 2010 Jun; 15 Suppl 1(s1):98-104. PubMed ID: 20586967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited setting.
    Revell AD; Alvarez-Uria G; Wang D; Pozniak A; Montaner JS; Lane HC; Larder BA
    Biomed Res Int; 2013; 2013():579741. PubMed ID: 24175292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-hospitalization, hospitalization, and post-hospitalization costs of patients with neurocysticercosis treated at the Instituto Nacional de Neurologia y Neurocirugia (INNN) in Mexico City, Mexico.
    Bhattarai R; Carabin H; Flores-Rivera J; Corona T; Proaño JV; Flisser A; Budke CM
    Rev Inst Med Trop Sao Paulo; 2018; 60():e20. PubMed ID: 29846471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicines policy, access and use in Mexico: a systematic literature review 2000-2022.
    Vargas López LC; Chávez Gallegos D; Blanco Borjas DM; Wirtz VJ
    Drugs Context; 2024; 13():. PubMed ID: 38384930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, Mexico.
    Cepeda JA; Beletsky L; Abramovitz D; Saldana CR; Kahn JG; Bañuelos A; Rangel G; Arredondo J; Vickerman P; Bórquez A; Strathdee SA; Martin NK
    Lancet Reg Health Am; 2024 Feb; 30():100679. PubMed ID: 38327278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metrics of sexual behavior stigma among cisgender men who have sex with men in Mexico: exploratory and confirmatory factor analyses.
    Wiginton JM; Murray SM; Algarin AB; Baral SD; Sanchez TH; Smith LR
    BMC Infect Dis; 2022 Aug; 22(1):690. PubMed ID: 35964006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Study of the Seroprevalence of HIV, HCV, and HBV in Blood Donors at a Blood Bank of Western Mexico.
    Guerrero-García JJ; Zúñiga-Magaña AG; Barrera-De León JC; Magaña-Duarte R; Ortuño-Sahagún D
    Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effectiveness of respondent-driven and venue-based sampling for identifying undiagnosed HIV infection among cisgender men who have sex with men and transgender women in Tijuana, Mexico.
    Pines HA; Semple SJ; Magis-Rodríguez C; Harvey-Vera A; Strathdee SA; Patrick R; Rangel G; Patterson TL
    J Int AIDS Soc; 2021 Mar; 24(3):e25688. PubMed ID: 33759361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study.
    Monteiro JF; Marshall BD; Escudero D; Sosa-Rubí SG; González A; Flanigan T; Operario D; Mayer KH; Lurie MN; Galárraga O
    AIDS Behav; 2015 Sep; 19(9):1579-88. PubMed ID: 25307025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.
    Siapka M; Remme M; Obure CD; Maier CB; Dehne KL; Vassall A
    Bull World Health Organ; 2014 Jul; 92(7):499-511AD. PubMed ID: 25110375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
    Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
    BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?
    Caro-Vega Y; Volkow P; Sierra-Madero J; Colchero MA; Crabtree-Ramírez B; Bautista-Arredondo S
    AIDS Res Treat; 2013; 2013():170417. PubMed ID: 24396592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men.
    Bautista-Arredondo S; Colchero MA; Romero M; Conde-Glez CJ; Sosa-Rubí SG
    PLoS One; 2013; 8(9):e72616. PubMed ID: 24039786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National prevalence and trends of HIV transmitted drug resistance in Mexico.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Ormsby CE; Hernández-Juan R; Andrade-Villanueva J; González-Hernández LA; Torres-Escobar I; Navarro-Álvarez S; Reyes-Terán G;
    PLoS One; 2011; 6(11):e27812. PubMed ID: 22110765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.